Hear why Neuralink co-founder Max Hodak says the screen era is ending at TechCrunch Disrupt 2026

Brain-computer interfaces can restore lost senses and may eventually augment human capabilities.

Max Hodak, co-founder of Neuralink, is scheduled to speak at TechCrunch Disrupt 2026 about the end of the screen era. His company, Science Corporation, is developing a biohybrid brain-computer interface and has begun U.S. human trials for its technology. Hodak's session, "Beyond Screens," will explore how brain-computer interactions can create new ways to engage with machines. Science Corporation's PRIMA implant has already restored vision in individuals with severe sight loss by beaming captured scenes to an implanted retinal chip. The company has raised $230 million in Series C funding at a $1.5 billion valuation. Hodak also envisions applications for brain-implanted sensors in healing damaged brain cells, seizure prediction, and treating conditions like Parkinson's disease. TechCrunch Disrupt 2026 will take place in San Francisco from October 13-15, focusing on sustainable AI companies and featuring over 250 sessions.

Hodak's Science Corporation is advancing beyond traditional screens to develop interfaces that integrate directly with the human brain. This shift signifies a move towards more intuitive and adaptive human-machine interactions, potentially transforming how we interact with technology in everyday life and for medical purposes. The company's success in restoring vision through its PRIMA implant demonstrates the tangible progress in this field.

The substantial funding and high valuation indicate strong investor confidence in the future of neural engineering and brain-computer interfaces. As Science Corporation expands its research into cognitive and mobility assistance, and even neurological disorder treatment, this area of technology is poised for significant growth and impact across healthcare and beyond.